(Total Views: 521)
Posted On: 12/02/2021 7:32:41 AM
Post# of 153905

Perhaps our Covid-19 play will be Long-haulers. The market for Leronlimab will be huge. According to this article, as many as 1% of all hospitalized patients are having long term CNS problems.
https://www.reuters.com/business/healthcare-p...021-12-01/
https://www.reuters.com/business/healthcare-p...021-12-01/

